Schonfeld Strategic Advisors’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-48,650
Closed -$2.74M 2212
2020
Q4
$2.74M Buy
+48,650
New +$2.39M 0.04% 530
2020
Q3
Sell
-41,138
Closed -$2.29M 1751
2020
Q2
$2.29M Buy
41,138
+19,370
+89% +$1.12M 0.06% 374
2020
Q1
$1.1M Buy
+21,768
New +$1.46M 0.07% 336
2019
Q1
Sell
-29,140
Closed -$1.44M 1362
2018
Q4
$1.44M Buy
+29,140
New +$1.75M 0.06% 383
2018
Q3
Sell
-4,400
Closed -$229K 1074
2018
Q2
$229K Buy
+4,400
New +$230K 0.01% 675
2018
Q1
Sell
-7,226
Closed -$423K 1024
2017
Q4
$423K Buy
+7,226
New +$410K 0.03% 503
2017
Q2
Sell
-6,321
Closed -$472K 818
2017
Q1
$472K Sell
6,321
-28,866
-82% -$2.09M 0.05% 377
2016
Q4
$2.37M Buy
+35,187
New +$2.27M 0.31% 94

Other funds holding NUVA

Schonfeld Strategic Advisors's NUVA Position: Q1 2021 in Review

Schonfeld Strategic Advisors sold out of NuVasive, Inc. (NUVA) in Q1 2021, closing a stake of 48,650 shares — an estimated $2.74M sold.

Schonfeld Strategic Advisors first reported a position in NUVA in Q4 2016 and held it in 8 quarters. The position peaked at $2.74M in Q4 2020. 261 funds tracked by Wall St. Rank hold NUVA as of Q1 2021.

  • Schonfeld Strategic Advisors reported no remaining NuVasive, Inc. position as of Q1 2021 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 48,650 NuVasive, Inc. shares in Q1 2021, an estimated $2.74M.
  • Schonfeld Strategic Advisors first reported a position in NuVasive, Inc. in Q4 2016 and held it in 8 quarters.
  • Schonfeld Strategic Advisors's NuVasive, Inc. position peaked at $2.74M in Q4 2020.
  • 261 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2021, filed 17 May 2021.